Pulse Biosciences, Inc. (PLSE)
47.90
-1.93
(-3.87%)
USD |
NASDAQ |
Oct 02, 16:00
47.91
+0.01
(+0.02%)
After-Hours: 20:00
Pulse Biosciences Net Income (Quarterly) : -24.66M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -24.66M |
| March 31, 2026 | -18.58M |
| December 31, 2025 | -17.43M |
| September 30, 2025 | -19.38M |
| June 30, 2025 | -19.17M |
| March 31, 2025 | -16.80M |
| December 31, 2024 | -19.38M |
| September 30, 2024 | -12.68M |
| June 30, 2024 | -11.38M |
| March 31, 2024 | -10.14M |
| December 31, 2023 | -11.93M |
| September 30, 2023 | -10.57M |
| June 30, 2023 | -9.91M |
| March 31, 2023 | -9.801M |
| December 31, 2022 | -9.197M |
| September 30, 2022 | -18.04M |
| June 30, 2022 | -14.00M |
| March 31, 2022 | -17.27M |
| December 31, 2021 | -15.42M |
| September 30, 2021 | -14.28M |
| June 30, 2021 | -15.32M |
| Date | Value |
|---|---|
| March 31, 2021 | -18.64M |
| December 31, 2020 | -13.75M |
| September 30, 2020 | -12.90M |
| June 30, 2020 | -11.33M |
| March 31, 2020 | -11.87M |
| December 31, 2019 | -13.79M |
| September 30, 2019 | -11.75M |
| June 30, 2019 | -11.36M |
| March 31, 2019 | -10.08M |
| December 31, 2018 | -8.953M |
| September 30, 2018 | -10.76M |
| June 30, 2018 | -9.163M |
| March 31, 2018 | -8.668M |
| December 31, 2017 | -8.703M |
| September 30, 2017 | -7.486M |
| June 30, 2017 | -6.18M |
| March 31, 2017 | -3.198M |
| December 31, 2016 | -2.809M |
| September 30, 2016 | -2.767M |
| June 30, 2016 | -2.258M |
| March 31, 2016 | -1.684M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Lucid Diagnostics, Inc. | -11.69M |
| Accuray, Inc. | -1.941M |
| Micron Solutions, Inc. | -- |
| IDEXX Laboratories, Inc. | 338.41M |
| Neogen Corp. | -11.30M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.434M |
| Total Expenses (Quarterly) | 25.09M |
| EPS Diluted (Quarterly) | -0.3563 |
| Enterprise Value | 3.296B |
| Gross Profit Margin (Quarterly) | 37.10% |
| Profit Margin (Quarterly) | -5.68K% |
| Earnings Yield | -2.45% |
| Normalized Earnings Yield | -2.452 |